| Joseph D Lago, MD | |
|
260 International Cir, San Jose, CA 95119-1130 | |
| (408) 972-7000 | |
| Not Available |
| Full Name | Joseph D Lago |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 260 International Cir, San Jose, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144306671 | NPI | - | NPPES |
| 00A257790 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A25779 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joseph D Lago, MD 1800 Harrison St Fl 7, Oakland, CA 94612-3429 Ph: (510) 625-6262 | Joseph D Lago, MD 260 International Cir, San Jose, CA 95119-1130 Ph: (408) 972-7000 |
News Archive
HHS Secretary Kathleen Sebelius today announced the awarding of $96 million in grants to increase diversity in the health professions workforce and encourage nurses to choose careers as nurse educators.
Poor oral health and hygiene are increasingly recognized as major risk factors for pneumonia among the elderly. To identify modifiable oral health-related risk factors, lead researcher Toshimitsu Iinuma, Nihon University School of Dentistry, Japan, and a team of researchers prospectively investigated associations between a constellation of oral health behaviors and incidences of pneumonia in the community-living of elders 85 years of age or older.
Karolinska Institutet has received a grant of SEK 100 million from the Knut and Alice Wallenberg Foundation for a regenerative medicine research centre - the Wallenberg Institute for Regenerative Medicine (WIRM). This funding will give Karolinska Institutet a unique opportunity to concentrate on new and pioneering research, with a special focus on the blood system.
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics using its Targeted Antibody Payload (TAP) technology, today announced the presentation of encouraging clinical data for the Company's lorvotuzumab mertansine (IMGN901) targeted anticancer compound at the 35th European Society for Medical Oncology (ESMO) Conference being held in Milan, Italy, October 8-12, 2010.
› Verified 2 days ago
Anna Nguyen, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2105 Forest Ave, San Jose, CA 95128 Phone: 408-947-2500 | |
Shalin Hira Patel, M.D Emergency Medicine Medicare: Medicare Enrolled Practice Location: 225 N Jackson Ave, San Jose, CA 95116 Phone: 408-923-7121 | |
Tony Hue-dan Yuan, M.D Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 North Jackson Avenue, San Jose, CA 94608 Phone: 510-350-2777 | |
Rhys Vincent Dapar, M.D Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2425 Samaritan Drive, San Jose, CA 95124 Phone: 408-559-2011 | |
Xiao Wang, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Hospital Pkwy, San Jose, CA 95119 Phone: 408-362-4740 | |
Thomas Gildea, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2105 Forest Ave, San Jose, CA 95128 Phone: 408-947-2500 | |
Jacob Benford, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 North Jackson Avenue, San Jose, CA 95116 Phone: 408-923-7121 |